ArticlePDF Available

Obtaining Consent for Organ Donation from a Competent ICU Patient Who Does Not Want to Live Anymore and Who is Dependent on Life-Sustaining Treatment; Ethically Feasible?

Authors:
  • 1. Erasmus University Rotterdam and 2. Natural History Museum Rotterdam

Abstract

We anticipate a further decline of patients who eventually will become brain dead. The intensive care unit (ICU) is considered a last resort for patients with severe and multiple organ dysfunction. Patients with primary central nervous system failure constitute the largest group of patients in which life-sustaining treatment is withdrawn. Almost all these patients are unconscious at the moment physicians decide to withhold and withdraw life-sustaining measures. Sometimes, however competent ICU patients state that they do not want to live anymore because of the severity of their illness or the poor prognosis and ask for withdrawal of life-sustaining measures like mechanical ventilation. Do we consider the unconscious patient as potential organ donor before withdrawal of mechanical ventilation? This is paradoxically rare in the case of the conscious ICU patient. Is it practically possible and ethically feasible to obtain consent for organ donation from this group of patients?
EMPIRICAL ETHICS
Obtaining consent for organ donation from a
competent ICU patient who does not want to live
anymore and who is dependent on life-sustaining
treatment; ethically feasible?
Jelle L Epker*, Yorick J de Grootand Erwin J O Kompanje*
*Department of Intensive Care, Erasmus MC University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands;
Department of Anaesthesiology, University Medical Center Utrecht, The Netherlands
Corresponding author: Jelle L Epker E-mail: j.epker@erasmusmc.nl
Abstract
We anticipate a further decline of patients who eventually will become brain dead. The intensive care unit
(ICU) is considered a last resort for patients with severe and multiple organ dysfunction. Patients with
primary central nervous system failure constitute the largest group of patients in which life-sustaining
treatment is withdrawn. Almost all these patients are unconscious at the moment physicians decide
to withhold and withdraw life-sustaining measures. Sometimes, however competent ICU patients
state that they do not want to live anymore because of the severity of their illness or the poor prognosis
and ask for withdrawal of life-sustaining measures like mechanical ventilation. Do we consider the
unconscious patient as potential organ donor before withdrawal of mechanical ventilation? This is
paradoxically rare in the case of the conscious ICU patient. Is it practically possible and ethically
feasible to obtain consent for organ donation from this group of patients?
Introduction
Since the first observational descriptions of brain dead
patients by French and German neurologists in the late
1950s, many thousands of artificially ventilated patients
in intensive care units worldwide have been declared
dead after the determination of irreversible failure of deter-
mined brain functions, and in almost all cases in favour
of organ donation for transplantation.
1,2
Brain death has
always been a rare outcome of intensive care treatment
of patients with severe brain damage due to traumatic
brain injury, or severe forms of stroke (subarachnoid haem-
orrhage [SAH] and intracerebral haemorrhage). Recently
it was demonstrated that the percentage contribution of
brain dead organ donations to the total of organ donations
has been decreasing significantly in the Netherlands in the
past 15 years.
3
Due to changes in demographics, increased
traffic safety, improved treatments like early coiling of
cerebral aneurysms and legislation prohibiting smoking
(an important risk factor for SAH) in public places we
anticipate a further decline of patients who eventually
will become brain dead.
3
Considering the fact that the
brain dead donor is the ideal organ donor, since only
when brain dead is diagnosed there’s the possibility
to procure the heart and the organs will generally have
a better quality, an anticipated decline in brain dead
donors means a further setback for transplantation medi-
cine. Therefore many initiatives are developed and
deployed in order to decrease the gap between patients
awaiting an organ and the number of actual organ
donors. These initiatives include a better organization of
donor care on a national, regional and hospital level
inspired by the Spanish model or a change in the system
of consent.
4
Several European countries like Spain,
France, Belgium, Austria and Sweden adapted a form of
Jelle L Epker, MD (1972) studied medicine from 1991 to 1998 and
specialised in general and intensive care medicine. Since 2006 he has
been a staff member of the Department of Intensive Care of the Erasmus
MC. Fields of interest are: intensive care neurology and end-of-life issues;
the letter is the subject of his PhD thesis research.
Yorick de Groot is resident anesthesiologist at the Department of
Anesthesiology, Intensive Care and Emergency Medicine at the
University Medical Center in Utrecht. He obtained his PhD in 2012
with the thesis ‘Organ Donor Recognition, practical and ethical
considerations’ at the Department of Intensive Care, Erasmus MC
Rotterdam.
Erwin J O Kompanje (1959) is a clinical ethicist specialising in intensive
care medicine and senior researcher at the Department of Intensive Care
of the Erasmus MC in Rotterdam. His fields of interest are: informed
consent, brain death and organ donation, and withdrawal of treatment
and palliative care on the ICU.
DOI: 10.1177/1477750912474762 Clinical Ethics 2013; 8:2933
presumed consent or opt-out.
5
Some North European
countries like the UK, Denmark Germany and the
Netherlands have considered a system of opt-out but even-
tually choose to maintain their current system of opt-in.
6,7
Taking into account the diminishing supply and the
growing need for organ transplantation, one has to
pursue and analyse every potential area of improvement.
The intensive care unit (ICU) is considered a last
resort for many patients with severe and multiple organ
dysfunction. Therefore it is the hospital department with
the highest mortality rate. Approximately 15% of all
admitted patients die on a mixed ICU. End of life care is
considered a vital part of the ICU. The majority of the
patients who die on the ICU die as a result of withholding
or withdrawing life sustaining treatment.
8
According to
a paper by Sprung et al.
9
the primary reasons for the
end of life decisions are unresponsiveness to therapy
(no diagnosis reported in the paper), neurological
reasons, chronic disease and multiorgan failure. In a
recent paper, Verkade et al.
10
studied the incidence of
withdrawal of life-sustaining treatment in various group
of patients in a single centre, mixed ICU in the
Netherlands. Patients with primary brain failure consti-
tuted the largest group of patients (86/174, 49.4%) in
which life-sustaining treatment was withdrawn.
Specifically this group of patients is most likely to be eli-
gible to eventually donate organs after death, but only a
few will eventually reach the state of brain death. For
this reason donation of organs after circulatory death is
increasingly considered. In the Netherlands the number
of donations after circulatory death increased from 118
patients in the period 1995 1999 to 453 patients in the
period 2005 2009 according the annual reports of the
Dutch Transplant Foundation.
3,11
At the same time the
amount of brain dead organ donors is significantly declin-
ing. Nowadays in many countries, organ donation after cir-
culatory death forms an important source for kidney, liver
and lung transplantation. All these patients are deeply
unconscious or deeply sedated at the moment life-
sustaining measures are withdrawn.
12
However sometimes competent ICU patients, who are
dependent on intensive care measures like mechanical
ventilation, state that they do not want to live anymore
because of the severity of their illness and the poor progno-
sis and ask for withdrawal of life-sustaining measures in
order to die.
13
In most cases in the Netherlands, the auton-
omy of these patients is respected and life-sustaining treat-
ment is then indeed withdrawn. Recently we described two
conscious patients who died on the ICU after they asked
for withdrawal of life sustaining treatment.
13
In which
way do they differ, besides the level of consciousness,
from the other patients in which we withdraw treatment
and in which we consider organ donation? Why do we
not consider these conscious patients as potential organ
donors before withdrawal of mechanical ventilation?
There is some experience with organ donation after
planned deliberate termination of life (euthanasia) in
Belgium,
14,15
but we are not aware of documented cases
in which ICU physicians ask patients, before withdrawal
of life-sustaining treatment, if they are willing to donate
their organs after death. In the light of the scarcity of
organ donors, perhaps we have to reconsider this point
of view. The aim of this paper is to discuss the pros and
cons of such a change in end of life care, focusing on
the current ethics and the practical feasibility.
Scenarios
The following two cases that have been selected to engage
the discussion of ethics.
Patient A, a 45-year-old electrician, is admitted to the
general ICU after a fall from a ladder. The fall resulted in
fractures of three cervical and one lumbar vertebra, and
mild traumatic head injury. During his stay on the ICU
he shows no improvements of his tetraplegic status. In
the weeks thereafter it is impossible to wean the patient
from the mechanical ventilator. He eventually regains
full consciousness and can communicate with eye blinking
and later by lip reading. He is informed about his clinical
situation. The patient is well aware of his situation and
the unavoidable restrictions for his future daily activities.
Several weeks after admission, he repeatedly expresses a
clear wish to have life sustaining treatment withdrawn
and asks the ICU team to take him off the mechanical
ventilator. After several deliberations between family
members, various physicians, nurses and a clinical ethicist
we agreed to offer him, according to his will, deep pallia-
tive sedation, followed by withdrawal of life sustaining
treatment. After initiation of intravenous administration
of midazolam the patient enters a deep sleep. Inotropic
support and mechanical ventilation were withdrawn.
After 15 minutes the patient died peacefully in the pres-
ence of his family.
Patient B a 45-year-old business administrator, is
admitted to the ICU with severe neurological injury
after a high-speed road traffic accident. A computed tomo-
graphy scan shows several subdural haematomas, a skull
fracture and compression of the brainstem. Because of
the low Glasgow Coma Score (GCS) score the patient is
intubated and connected to a mechanical ventilator.
When the patient is neurologically assessed by a neuro-
surgeon he has a GCS of E
1
M
1
V
1
, an absent pupil and
corneal reflexes. However because of some intact brain-
stem reflexes the patient is not considered to be brain
dead. After several weeks of ICU treatment, the patient
shows no neurological improvement. In a multidisciplinary
meeting it is decided to withdraw life-sustaining treatment
based on the poor prognosis of the patient. When discuss-
ing this decision with the family, the treating physician
also mentions the option of organ donation. Because the
patient is not registered in the national donor register,
the relatives of the patient are mandated by law to make
the decision regarding organ donation. After much discus-
sion they agree with organ donation according to the
protocol of donation after circulatory death (DCD). In
the presence of the family the mechanical ventilator and
other life sustaining therapy are withdrawn. The patient
dies after 30 minutes of cardiopulmonary arrest. After
30 Epker et al.
Clinical Ethics 2013 Volume 8 Number 1
the mandatory five-minute ‘no-touch’ period the patient is
transferred to the operation theatre for organ retrieval.
Discussion
When comparing both scenarios there are many simi-
larities but also some important differences. Both patients
die as result of an action, namely the withdrawal of life-
sustaining measures, which is done by the physician after
multidisciplinary deliberation.
16
While in the first scenario
the patient explicitly asks for the withdrawal of life sustain-
ing measures in order to die, in the latter case the decision
is made by a multidisciplinary group of physicians and
other health-care workers. Both patients were suitable
for organ transplantation after death but only the second
patient donated his organs after the physicians asked
consent of the family. The other, conscious, patient
could have decided if he wanted to donate one or more
organs, but was never approached with the question con-
cerning organ donation.
Essential in the decision process surrounding the
withdrawal of life-sustaining treatment in patients who
are awake, as we discussed in detail in our previous
paper, is respect for the autonomy of the patient. Dutch
care-givers have to respect, by law (medical treatment
agreement act [Wet Geneeskundige Behandelings
Overeenkomst]), the wishes of the patient if they are
understandable and within the accepted possibilities of
medical care.
17,18
This also implies that a doctor is not
allowed to start or continue a treatment that is not
wanted by the patient. This is clearly stated in article
450 of the above-mentioned law: ‘For all actions and treat-
ments within the treatment contract the explicit approval
of the patient is needed’. So there has to be no doubt con-
cerning the cognitive functioning and competency of the
patient.
13
According to Beauchamp and Childress an
autonomous action should be made by someone (1) who
acts intentionally, (2) with understanding of the conse-
quences at hand and (3) without controlling influences
that determine their action.
19
In the first case the decision
to withdraw life-sustaining therapy is made by the treating
physician after the explicit request of the patient. The
patient made this request with the knowledge that the
withdrawal of the mechanical ventilator and inotropic
medication will result in a certain death. He acted inten-
tionally with the limited means of communication he
had at his disposal and family or friends did not influence
his actions. Nevertheless he was not asked if he wanted to
use the option of donating organs after his death.
The ethical basis of deciding to donate organs after
death is that it is ideally an autonomous choice, made by
the individual when he or she was healthy of mind. The
central donor registry, which is an essential tool with
regard to organ donation in the Netherlands, is based
on this same respect for patient autonomy.
20
When an
individual decides that he or she wants to donate
organs or tissues after death, then this is effectuated, if
possible, in almost all cases. In the case of no registration
in the donor registry, the relatives of the patient are
approached to consider permission for organ removal
after death of the patient, as is described in the second
scenario.
In the Netherlands, individuals can ask a physician for
withdrawal of treatment, but also for intentional termin-
ation of life. This presupposes absolute voluntariness
(seen from the patient) and a deliberate act (seen from
the physician). It excludes every form of intentional,
active, direct, non-voluntary termination of life. In the
Dutch ‘Termination of Life on Request and Assisted
Suicide Act’, the requirements of due care are described.
21
This above-mentioned Act requires that the physician:
Holds the conviction that the request by the patient is
voluntary and well considered;
Holds the conviction that the patient’s suffering is lasting
and unbearable;
Has informed the patient about the situation and about
the prospects;
Holds the conviction that there is no other reasonable
alternative in the light of the patients situation;
Has consulted at least one other independent physician
who must have seen the patient and given a written
opinion on the due care criteria;
Has terminated a patient’s life or provided assisted suicide
with due medical care and attention.
The same requirements, with exception of the last, are
applicable for the scenario in which a competent patient
on the ICU asks for termination of mechanical ventilation
and other life-sustaining measures. In such a situation,
taking the above-mentioned requirements in consider-
ation, the request has to be taken seriously. If approved,
the patient is brought to sleep with sedatives after which
mechanical ventilation is withdrawn and the patient
dies. Euthanasia (deliberate termination of life after injec-
tion of euthanatica) is very rare in the ICU setting in the
Netherlands.
22
Withdrawal of life-sustaining measures is
however common.
8,9,12
Why then do we not just ask patients before with-
drawal of mechanical ventilation whether they are
willing to donate their organs? There are four arguments
that can explain why the patient is not confronted with
the donation request:
(1) The patient is not recognized as a potential donor;
(2) There is fear of creating a conflict of interest;
(3) There is fear of creating a self-fulfilling prophecy;
(4) There is fear of harming the doctor-patient relation.
The most obvious reason why the patient is not
approached is probably because he’s simply not recognized
as a potential donor. In the, often emotional, process of
handling the patient’s request of withdrawing treatment,
the focus of the medical team will primarily be on the
legal and ethical issues involved with that process and
therefore the possibility of organ donation will just not
enter their mind in that stage. Since there is, until now,
no documented experience with organ donation in these
situations, the likelihood that this way of thinking will
Obtaining consent for organ donation 31
Clinical Ethics 2013 Volume 8 Number 1
change in short term is not great, thereby creating inevita-
bly a vicious circle.
Some scholars will reason that a conflict of interest
will arise in such a situation, but we do consider this a
moral fiction. The autonomous patient asks voluntarily
for termination of life (as in the Belgium cases of organ
donation described by Ysebaert et al.
14
) or termination
of life sustaining measures. It is important to realize that
it is not the physician who initiated this, but the patient
himself. The physician follows the voluntary and well-
considered request. What if the patient asks, besides the
request for termination of life or withdrawal of mechanical
ventilation, for organ donation after death? Do we have
reasons to reject this? We cannot conclude this. We there-
fore argue that there are no moral objections for asking
the patient for organ donation if the request for life termi-
nation or withdrawal of ventilation is granted. A conflict
of interest can only then arise when the physician
himself initiates the process of considering withdrawing
of life support for the patient. Although we certainly
appreciate an open patient/physician relationship in
which all aspects of treatment can be discussed, the initiat-
ive for withdrawing treatment in a conscious patient (in
analogy with euthanasia) should always come from the
patient alone. A ‘helping hand’ in this decision process
is indeed, in cases like this, the key to an unwanted con-
flict of interest.
Another point of concern that some will mention is
the introduction of a potential self-fulfilling prophecy.
At this moment when this patient category is not yet
recognized as a potential donor this risk is negligible.
However, when this changes, the general public may be
inclined to think that physicians would be tempted to be
deliberately pessimistic about the patient’s prognosis to
enhance the patient change of request for withdrawal of
treatment. Although this is a non-rational factor, it is
unfortunately in concurrence with the documented fear
of the general public that doctors will be tempted to pre-
maturely declare death in order to procure organs.
23
Distrust of society and henceforth a negative discussion
in the lay press, although non-rational, should be regarded
as a real threat for the proposed scenario.
In fact, all the arguments proposed in this paper are
within Dutch law. Moreover the corner stone for this
proposal is that the patient himself must first ask for treat-
ment withdrawal and a second (independent) physician
must approve. Therefore it is almost impossible to create
a self-fulfilling prophecy in this scenario. The proposed
scenario is in fact fully in line with, the generally well
supported intention of the Organ Donation Act in the
Netherlands; giving everyone the chance to donate his
or her organs after dying.
24
A last argument that may be put against this proposal
is the fact that the patient himself may experience pressure
in the choice he has to make. Some will argue that the
patient will be aware of the fact that ‘yes’ to the donation
question is the desired answer and since the patient is
dependent on his physician to withdraw treatment and
the provision of care in that process, the patient may
feel forced to give an answer that pleases the care-giver,
even though it may be in contradiction with his personal
values. However, a patient that dares to ask his treating
physician to stop a treatment that has been supported
by his physician shows already a high level of self-
differentiation. The fact that both doctor and patient
have been able to discuss such a delicate matter together
gives proof of a well-formed doctor –patient relationship.
Therefore we think it’s highly unlikely that a well self-
differentiated patient with a good doctor– patient relation
will be tempted to choose something that is against his
own principles or values in such a situation.
Organ donation after circulatory death is legally and
ethically accepted in many Western countries, taking
the dead donor rule in consideration. The dead donor
rule is the ethical and legal rule that requires that donors
are not to be killed to obtain their organs.
25
The dead
donor rule is vital for the donation and transplantation
system and helps to maintain the public trust in organ
donation after death. After five minutes of circulatory
arrest with no ventilation the patient is considered dead
and organ removal can take place. The situation is equal
in cases where an unconscious patient with devastating
neurological damage dies after withdrawal of mechanical
ventilation, as in cases where a sedated patient, who was
conscious before sedation, dies after withdrawal of mech-
anical ventilation. Both patients are then equal and suit-
able for organ donation. For this reason we see no
obstacles for organ donation in the described context.
Conclusions
In a medical community in which withdrawal of life-
sustaining measures in unconscious and in conscious
ICU patients is accepted, where organ donation after
death is common practice, and in which there is a shortage
of organs for transplantation, there can be no moral objec-
tion to ask certain conscious ICU patients to donate their
organs after death. Although withdrawal of mechanical
ventilation on request of the patient on the ICU is rare
and therefore the number of organs that come available
is limited, it is still well worth considering. We argue
that there are no valid moral and legal objections against
it; it is ethically feasible and practically possible to ask
the patients for organ donation after death.
Conflict of interest: None.
Funding: None.
References and notes
1 Wertheimer P, Jouvet M, Descotes J. [Diagnosis of death of the
nervous system in comas with respiratory arrest treated by artificial
respiration]. Presse Med 1959;67:878
2 Mollaret P, Goulon M. [The depassed coma (preliminary memoir)].
Rev Neurol (Paris) 1959;101:3– 15
3 Kompanje EJ, de Groot YJ, Bakker J. Is organ donation from brain
dead donors reaching an inescapable and desirable nadir?
Transplantation 2011;91:1177–80
32 Epker et al.
Clinical Ethics 2013 Volume 8 Number 1
4 Rodriguez-Arias D, Wright L, Paredes D. Success factors and ethical
challenges of the Spanish Model of organ donation. Lancet 2010;
376:1109– 12
5 Gevers S, Janssen A, Friele R. Consent systems for post mortem
organ donation in Europe. Eur J Health Law 2004;11:175– 86
6 Fabre J, Murphy P, Matesanz R. Presumed consent: a distraction
in the quest for increasing rates of organ donation. BMJ 2010;
341:c4973
7 Bird SM, Harris J. Time to move to presumed consent for organ
donation. Br Med J 2010;340:c2188
8 Sprung CL, Cohen SL, Sjokvist P, et al. End-of-life practices in
European intensive care units: the Ethicus Study. JAMA 2003;
290:790–7
9 Sprung CL, Woodcock T, Sjokvist P, et al. Reasons, considerations,
difficulties and documentation of end-of-life decisions in European
intensive care units: the ETHICUS Study. Intensive Care Med
2008;34:271– 7
10 Verkade MA, Epker JL, Nieuwenhoff MD, Bakker J, Kompanje EJ.
Withdrawal of life-sustaining treatment in a mixed intensive care
unit: most common in patients with catastropic brain injury.
Neurocrit Care 2012;16:130– 5
11 Leiden van HA, Heemskerk MBA, Haase-Kromwijk BJJM. Annual
Report of the Dutch Transplant Foundation. Leiden: Dutch
Transplant Foundation, 2011
12 Epker JL, Bakker J, Kompanje EJ. The use of opioids and sedatives
and time until death after withdrawing mechanical ventilation and
vasoactive drugs in a dutch intensive care unit. Anesth Analg
2011;112:628– 34
13 van der Hoven B, de Groot YJ, Thijsse WJ, Kompanje EJ. What to
do when a competent ICU patient does not want to live anymore but
is dependent on life-sustaining treatment? Experience from The
Netherlands. Intensive Care Med 2010;36:2145– 8
14 Ysebaert D, Van Beeumen G, De Greef K, et al. Organ procure-
ment after euthanasia: Belgian experience. Transplant Proc 2009;
41:585–6
15 Van Raemdonck D, Verleden GM, Dupont L, et al. Initial experi-
ence with transplantation of lungs recovered from donors after
euthanasia. In: Weimar W, Bos MA, Busschbach JJV, eds. Organ
Transplanation: Ethical, Legal and Psychosocial Aspects. Pabst,
Lengerich, 2011, 197209
16 Miller FG, Truog RD, Brock DW. Moral fictions and medical ethics.
Bioethics 2010;24:453– 60
17 Spreeuwenberg C. [The Law on Medical Treatment Agreement:
viewpoint of the professional group]. Ned Tijdschr Geneeskd
1994;138:2452– 5
18 Patient Rights in the Netherlands. Centre for Biomedical Ethics and
Law Leuven, 2008
19 Beauchamp TL, Childress JF. Principles of Biomedical Ethics.
New York: Oxford University Press, 2009
20 Dutch Donor Registry. Website of the central donor registration organiz-
ation in The Netherlands. The Hague: Ministry of Health Welfare and
Sports, 2012
21 Korthals AH, Borst E. The Termination of Life on Request and Assisted
Suicide Act. The Hague: Ministry of Health Welfare and Sports, 2001
22 Kompanje EJ, de Beaufort ID, Bakker J. Euthanasia in intensive care:
a 56-year-old man with a pontine hemorrhage resulting in a
locked-in syndrome. Crit Care Med 2007;35:2428– 30
23 Morgan SE, Harrison TR, Afifi WA, Long SD, Stephenson MT. In
their own words: the reasons why people will (not) sign an organ
donor card. Health Commun 2008;23:23– 33
24 Borst E, Sorgdrager S. The Organ Donation Act. The Hague: Ministry
of Health Welfare and Sports, 1996
25 Robertson JA. The dead donor rule. Hastings Cent Rep 1999;29:6– 14
Obtaining consent for organ donation 33
Clinical Ethics 2013 Volume 8 Number 1
Article
Full-text available
De procedure die euthanasie met donatie na circulatoire vaststelling van de dood (DCDD) combineert staat bekend als "orgaandonatie na euthanasie"(ODE). De eerste internationale Roundtable over ODE werd gehouden tijdens het internationale, huisartsengeneeskundige WONCA-congres in 2021 als onderdeel van een scoping review. Het doel was de praktijk en problemen van ODE te inventariseren om patiënten, professionals en beleidsmakers te adviseren, de ontwikkeling van verantwoorde richtlijnen te bevorderen en hulp te bieden bij voorliggende vraagstukken. Dit werd uiteindelijk door middel van literatuuronderzoek, en nationale en internationale stakeholder-bijeenkomsten bereikt. Tot 2021 werd 286 keer ODE uitgevoerd in Canada, Nederland, Spanje en België, waaronder acht maal ODE gestart vanuit huis (ODEH). Euthanasie werd 17.217 keer uitgevoerd (2020) in de acht landen waar ODE mogelijk is. Tot en met 2021, hebben 837 patiënten (tot 14% van de ontvangers van DCDD-donoren), organen afkomstig van ODE ontvangen. ODE herbergt enkele belangrijke ethische aandachtspunten met betrekking tot de autonomie van de patiënt. Het gaat hierbij met name om potentiele druk tussen het verzoek om euthanasie en organen te doneren en de verhoogde belasting voor de ernstig zieke euthanasie patiënten die bij ODE aanwezig is. | 1
Article
Full-text available
La procédure combinant l'aide médicale à mourir (AMM) et les dons d'organes après constatation du décès circulatoire (DCDC) est connue sous le nom de don d'organes après euthanasie (DOE). La première table ronde internationale sur le don d'organes après euthanasie s'est tenue lors de la conférence de médecine familiale de la WONCA en 2021, dans le cadre d'une étude de la portée. Elle avait pour but de documenter les pratiques et les questions connexes afin de conseiller les patients, les professionnels et les décideurs, de faciliter l'élaboration de lignes directrices responsables et de permettre une meilleure gestion des problèmes existants. À cet effet, des recherches documentaires ont été effectuées et des réunions nationales et internationales de parties prenantes ont été organisées. Jusqu'en 2021, le DOE avait été réalisé 286 fois au Canada, aux Pays-Bas, en Espagne et en Belgique, dont huit cas à domicile (DOED). L’AMM a été prodiguée 17 217 fois (2020) dans les huit pays où le DOE est autorisé. Jusqu’en 2021, 837 patients (jusqu'à 14 % des receveurs de donneurs de DCDC) avaient reçu des organes par DOE. Le DOE soulève d'importantes préoccupations éthiques concernant l'autonomie des patients, le lien entre la demande d'AMM et la demande de don d'organes ainsi que le fardeau accru imposé aux patients gravement malades ayant bénéficié de l'AMM.
Article
Full-text available
REVISIÓN INTEGRAL Práctica y desafíos para la donación de órganos tras la asistencia médica en la muerte: Una revisión del alcance que incluye los resultados de la primera mesa redonda internacional en 2021 El procedimiento que combina la asistencia médica a la muerte (MAiD,por sus siglas en inglés) con las donaciones tras la determinación de lamuerte cardíaca (DCDD, por sus siglas en inglés) se conoce comodonación de órganos tras la eutanasia (ODE, por sus siglas en inglés). Laprimera mesa redonda internacional sobre la ODE se celebró durantela conferencia de medicina familiar de la WONCA de 2021 como partede una revisión del alcance. Su objetivo es documentar la prácticaylas cuestiones relacionadas a fin de asesorar a los pacientes los profesionales y losresponsables políticos, contribuyendo a la elaboración de directrices responsables yayudando a abordar los problemas. Para ello, se realizaron búsquedas bibliográficas Yse celebraron reuniones nacionales e internacionales con las partes interesadas.Hasta 2021, la ODE se realizó 286 veces en Canadá, los Países Bajos, España yBélgica, incluidos ocho casos de ODE desde el hogar (ODEH, por sus siglas eninglés). La MAiD fue suministrada 17.217 veces (2020) en los ocho países en los queestá permitida la ODE. Hasta 2021, 837 pacientes (hasta el 14% de los receptores dedonantes de DCDD) habían recibido órganos provenientes de una ODE. La ODEplantea algunas cuestiones éticas importantes relacionadas con la autonomía delpaciente, la relación entre la solicitud de la MAiD y la solicitud de donación deórganos y el consiguiente aumento de la carga que soportan los pacientesgravemente enfermos que reciben la MAiD
Article
Full-text available
The procedure combining medical assistance in dying (MAiD) with donation after circulatory determination of death (DCDD) is known as organ donation after euthanasia (ODE). The first international roundtable on ODE was held during the 2021 WONCA family medicine conference as part of a scoping review. Its aim was to document practice and related issues so as to advise patients, professionals and policymakers, aiding development of responsible guidelines and helping to navigate the issues. This was achieved through literature searches and national and international stakeholder meetings. Up to 2021, ODE was performed 286 times in Canada, the Netherlands, Spain and Belgium, including eight cases of ODE from home (ODEH). MAiD was provided 17,217 times (2020) in the eight countries where ODE is permitted. As of 2021, 837 patients (up to 14% of recipients of DCDD donors) had received organs from ODE. ODE raises some important ethical concerns involving patient autonomy, the link between the request for MAID and the request to donate organs and the increased burden placed on seriously ill MAiD patients.
Article
Deceased donation medicine involves unique ethical challenges. Physicians who are focused on deceased donation medicine as part of their practice can expect to encounter these challenges. The goal of this review is to identify and describe these challenges, highlight existing guidelines and policy regarding the management of these challenges and to describe how the donation physician role might promote ethical practice in deceased donation medicine. Themes of discussion include: Communication with families, interprofessional conflict, donation physician personal characteristics, donation clinical processes, health resource allocation, research and education, and remuneration. The information presented in this review can be used to inform development of recommendations and guidelines for the management of ethical challenges encountered by donation physicians.
Article
Full-text available
Context While the adoption of practice guidelines is standardizing many aspects of patient care, ethical dilemmas are occurring because of forgoing life-sustaining therapies in intensive care and are dealt with in diverse ways between different countries and cultures.Objectives To determine the frequency and types of actual end-of-life practices in European intensive care units (ICUs) and to analyze the similarities and differences.Design and Setting A prospective, observational study of European ICUs.Participants Consecutive patients who died or had any limitation of therapy.Intervention Prospectively defined end-of-life practices in 37 ICUs in 17 European countries were studied from January 1, 1999, to June 30, 2000.Main Outcome Measures Comparison and analysis of the frequencies and patterns of end-of-life care by geographic regions and different patients and professionals.Results Of 31 417 patients admitted to ICUs, 4248 patients (13.5%) died or had a limitation of life-sustaining therapy. Of these, 3086 patients (72.6%) had limitations of treatments (10% of admissions). Substantial intercountry variability was found in the limitations and the manner of dying: unsuccessful cardiopulmonary resuscitation in 20% (range, 5%-48%), brain death in 8% (range, 0%-15%), withholding therapy in 38% (range, 16%-70%), withdrawing therapy in 33% (range, 5%-69%), and active shortening of the dying process in 2% (range, 0%-19%). Shortening of the dying process was reported in 7 countries. Doses of opioids and benzodiazepines reported for shortening of the dying process were in the same range as those used for symptom relief in previous studies. Limitation of therapy vs continuation of life-sustaining therapy was associated with patient age, acute and chronic diagnoses, number of days in ICU, region, and religion (P<.001).Conclusion The limiting of life-sustaining treatment in European ICUs is common and variable. Limitations were associated with patient age, diagnoses, ICU stay, and geographic and religious factors. Although shortening of the dying process is rare, clarity between withdrawing therapies and shortening of the dying process and between therapies intended to relieve pain and suffering and those intended to shorten the dying process may be lacking. Figures in this Article While the principle that dying patients should be treated with respect and compassion is broadly accepted among health care professionals, medical practices for end-of-life care differ around the world. In the United States, medicine has moved from a paternalistic model to one that promotes autonomy and self-determination.1- 2 Patient expectations and preferences now help shape end-of-life practices, limiting the use of technologies that may prolong dying rather than facilitate recovery.1- 2 In Europe, patient-physician relationships are still somewhat paternalistic.3- 5 Different cultures and countries deal in diverse ways with the ethical dilemmas arising as a consequence of the wider availability of life-sustaining therapies.3- 4,6 Some have not adopted the Western emphasis on patient autonomy or methods of terminating life support.3- 4,6 In the past, patients died in intensive care units (ICUs) despite ongoing aggressive therapy.7 Theoretical discussions7 and attitudes of critical care professionals concerning these issues have been reported.4,8- 9 In North America, observational studies documenting physician behavior have noted changes in the modes of patient deaths10- 17 and an earlier abandonment of life-sustaining treatments.10 Although European observational studies have demonstrated withholding or withdrawing of life-sustaining treatments in 6% to 13.5% of patients admitted to the ICU and in 35% to 93% of dying patients, the results have come from individual countries.5,17- 21 The overall incidence of end-of-life practices in European ICUs is not known. Furthermore, no studies have been conducted to date comparing different European countries or regions to verify whether reported variations from questionnaire respondents4 are accurate. End-of-life actions in ICUs include withholding or withdrawing life-sustaining therapies,5,7- 21 and in Europe, community studies have described active euthanasia in the Netherlands22 and Belgium.23 At the time this study was conducted, euthanasia was legally practiced in only 1 European country, but withdrawing life-sustaining therapies was common.5,19,21 It is not known whether regional variations in attitudes toward use of euthanasia has any influence on local ICU practice. The objectives of this large multicenter study were to observe and describe actual end-of-life practices in ICUs of several European countries, to determine their overall incidence, to document variations in the pattern of practice, and to analyze similarities and differences in terms of variables that might explain the findings.
Article
Full-text available
Abbreviations BOS bronchiolitis obliterans syndrome DBD donor after brain death DCD donor after cardiac death FEV 1 forced expiratory volume in one sec-ond FVC forced vital capacity LTx lung transplantation PGD primary graft dysfunction 38 D. Van Raemdonck et al. Abstract Objectives: Donors after cardiac death (DCD) have increasingly provided organs for lung transplantation (LTx). The use of lungs from donors after euthanasia has not yet been report-ed. Methods: Between 01/2007-12/2009, 17/145 (11.7%) isolated LTx were performed from con-trolled DCD, including 4 (2.8%) after euthanasia. All donors expressed their wish for organ do-nation once their request for euthanasia was granted according to Belgian legislation. All donors suffered from an unbearable non-malignant disorder. Results: The warm ischemic time between circulatory arrest and cold flush of donor lungs was 14 [10-16] min. Total ischemic time until reperfusion of the graft was 329 [225-414] min for the first lung and 517 [346-547] min for the second lung. No severe graft dysfunction was ob-served beyond 24 hours. One recipient died in the ICU from a problem unrelated to the graft. The remaining patients were extubated after 2 [2-3] days and discharged from ICU after 7 [4-7] days and from hospital after 33 [23-36] days. FEV1 and FVC increased from 16 [15-21]% and 52 [51-59]% pre-transplant to 85 [61-94]% and 79 [63-84]% at the time of hospital dis-charge, respectively; (p<0.01). Actuarial 1-year and 3-year survival was 75%. Conclusion: Euthanasia donors accounted for 23.5% of all DCD lung donors with excellent post-transplant graft function and good early recipient outcome.
Article
Full-text available
To determine the incidence of withdrawal of life-sustaining treatment in various groups of patients in a mixed intensive care unit (ICU). Observational retrospective. Setting: University hospital mixed medical, neurological, neurosurgical and surgical ICU. All patients admitted to the ICU between 1 November 2006, and 31 October 2007. 1,353 Patients were admitted to our ICU between 1 November 2006, and 31 October 2007. During this period, 218 (16.1%) patients died in the ICU, 10 of which were excluded for further analysis. In 174 (83.7%) of the remaining 208 patients, life-sustaining treatment was withdrawn. Severe CNS injury was in 86 patients (49.4%) being the reason for withdrawal of treatment, followed by MODS in 67 patients (38.5%). Notably, treatment was withdrawn in almost all patients (95%) who died of CNS failure. Patients who died in the ICU were significantly older, more often admitted for medical than surgical reasons, and had higher SOFA and APACHE II scores compared with those who survived their ICU stay. Also, SOFA scores before discharge/death were significantly different from admission scores. Of the 1,135 patients who survived their ICU stay, only 51 patients (4.5%) died within 28 days after ICU discharge. In 83, 7% of patients who die in the mixed ICU life-sustaining treatment is withdrawn. Severe cerebral damage was the leading reason to withdraw life-sustaining treatment.
Article
Full-text available
Spain has the highest rate of organ donation in the world and is often cited as a successful example of presumed consent legislation. However, the country does not have an opt-out register, nor is public awareness of the 1979 legislation promoted. John Fabre, Paul Murphy, and Rafael Matesanz argue that the presumed consent legislation is dormant, and that Spain in fact demonstrates it is possible to have the highest rates of organ donation without recourse to presumed consent
Article
Full-text available
1These data account for WHO’s strategy to extend the so-called Spanish Model across the globe, and for the European Parliament’s decision to incorporate some of the elements of the Spanish model into its 2010 action plan on organ donation and transplantation. 2 In this Viewpoint, we explore the success factors of the Spanish system and look at whether these factors can be implemented in other countries. We also identify inherent ethical issues. Success factors of the Spanish Model include its legal approach and a comprehensive programme of education, communication, public relations, hospital reimbursement, and quality improvement. These factors have occasionally been implemented by other regions with success. 3
Article
Full-text available
If patients on the intensive care unit (ICU) are awake and life-sustaining treatment is suspended because of the patients' request, because of recovering from the disease, or because independence from organ function supportive or replacement therapy outside the ICU can no longer be achieved, these patients can suffer before they inevitably die. In The Netherlands, two scenarios are possible for these patients: (1) deep palliative (terminal) sedation through ongoing administration of barbiturates or benzodiazepines before withdrawal of treatment, or (2) deliberate termination of life (euthanasia) before termination of treatment. In this article we describe two awake patients who asked for withdrawal of life-sustaining measures, but who were dependent on mechanical ventilation. We discuss the doctrine of double effect in relation to palliative sedation on the ICU. Administration of sedatives and analgesics before withdrawal of treatment is seen as normal palliative care. We conclude that the doctrine of the double effect is not applicable in this situation, and mentioning it criminalised the practice unnecessarily and wrongfully.
Article
The brain dead patient is the ideal multiorgan donor. Conversely, brain death (BD) is an undesirable outcome of critical care medicine. Conditions that can lead to the state of BD are limited. An analysis showed that a (aneurysmal) subarachnoid hemorrhage, traumatic brain injury, or intracerebral hemorrhage in 83% precede the state of BD. Because of better prevention and treatment options, we should anticipate on an inescapable and desirable decline of BD. In this article, we offer arguments for this statement and discuss alternatives to maintain a necessary level of donor organs for transplantation.
Article
We studied the frequency of withdrawal of mechanical ventilation (MV) and/or vasoactive agents (VAs), the time until death, and dosages of opioids and sedatives in a Dutch academic intensive care unit (ICU), and compared these practices with international observations in this field. Retrospective data were collected from the electronic and paper files of all patients who died after withdrawal of treatment in a Dutch ICU between October 2006 and February 2007. In this period, 471 patients were admitted to the ICU, of whom 88 died (18%). In 60 of these patients (68%), MV and/or VAs were withdrawn. This group represented 13% of the total ICU population. Of the 60 patients for whom MV and/or VAs were withdrawn, 54 (90%) died after withdrawal of MV (with or without VAs). Six (10%) died after withdrawal of VAs only, 33 (55%) after withdrawal of MV in combination with VAs, and 21 (35%) after withdrawal of MV only. Death occurred after withdrawal of MV in combination with VAs after a median of 30 minutes (interquartile range [IQR], 10-195 minutes). When only MV was discontinued, the median time until death was 50 minutes (IQR, 15-530 minutes). When only VAs were withdrawn, patients died after a median of 45 minutes (IQR, 20-715 minutes). Ten patients (17%) did not receive opioids or sedatives in their last hours. Fifty patients received opioids in their last hours. Fentanyl, with a median dosage at time of death of 100 μg/h, was the most frequently used opioid. Forty (80%) of the 50 patients mentioned above received some kind of sedative until death. In the MV withdrawal group, 34 of the 54 patients (63%) received sedatives in the last hours of their lives: 16 (27%) received midazolam (median, 10 mg/h), 12 (22%) propofol (median, 160 mg/h), and 6 (11%) lorazepam (2.0 mg/h). Sedatives were administered to all patients in whom only VAs were withdrawn. Dutch patients who die in the ICU, or die after discharge from the ICU, die after MV and/or VAs are withdrawn. When treatments are withdrawn, death follows within 1 hour in most patients, which is a reflection of the severity of illnesses. At least 80% of patients receive opioids, and 67% receive sedatives until death. Fentanyl is the most used opioid, whereas midazolam is the most used sedative. Dosages of opioids and sedatives did not significantly exceed the ranges described as usual in the international literature.
Article
Given the UK’s modest 60% consent rate for donation of organs from brain stem dead donors, Sheila Bird and John Harris argue that allowing donation unless the donor has explicitly opted out would substantially increase the number of organs available